James H. Fox
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
James H. Fox has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Christopher A. Lowry
Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA
4 shared publications - James E. Hassell
Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America
3 shared publications - Mathew R. Arnold
Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA; Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA
3 shared publications - Philip H. Siebler
Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309-0354, USA
3 shared publications - Dominic Schmidt
Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309-0354, USA
2 shared publications - Heidi E. W. Day
Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA
2 shared publications
Latest Publications
- 1 October 2019
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 81, 151-160
Treatment with a heat-killed preparation of Mycobacterium vaccae after fear conditioning enhances fear extinction in the fear-potentiated startle paradigm
- 1 October 2019
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 81, 151-160
Treatment with a heat-killed preparation of Mycobacterium vaccae after fear conditioning enhances fear extinction in the fear-potentiated startle paradigm
- 1 November 2017
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 66, 70-84
Preimmunization with a heat-killed preparation of Mycobacterium vaccae enhances fear extinction in the fear-potentiated startle paradigm
- 1 November 2017
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 66, 70-84
Preimmunization with a heat-killed preparation of Mycobacterium vaccae enhances fear extinction in the fear-potentiated startle paradigm
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 7, 169
Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior
Corticotropin-releasing factor (CRF) is a 41-amino acid neuropeptide that is involved in stress-related physiology and behavior, including control of the hypothalamic-pituitary-adrenal (HPA) axis. Members of the CRF family of neuropeptides, including urocortin 1 (Ucn 1), Ucn 2, and Ucn 3, bind to the G protein-coupled receptors, CRF type 1 (CRF1) and CRF2 receptors. In addition, CRF binding protein (CRFBP) binds both CRF and Ucn 1 and can modulate their activities. There are multiple mechanisms through which CRF-related peptides may influence emotional behavior, one of which is through altering the activity of brainstem neuromodulatory systems, including serotonergic systems. Corticotropin-releasing factor and CRF-related peptides act within the dorsal raphe nucleus (DR), the major source for serotonin (5-HT) in the brain, to alter the neuronal activity of specific subsets of serotonergic neurons and to influence stress-related behavior. CRF-containing axonal fibers innervate the DR in a topographically organized manner, which may contribute to the ability of CRF to alter the activity of specific subsets of serotonergic neurons. CRF and CRF-related peptides can either increase or decrease serotonergic neuronal firing rates and serotonin release, depending on their concentrations and on the specific CRF receptor subtype(s) involved. This review aims to describe the interactions between CRF-related peptides and serotonergic systems, the consequences for stress-related behavior, and implications for vulnerability to anxiety and affective disorders.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 7, 169
Open AccessCorticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior
Corticotropin-releasing factor (CRF) is a 41-amino acid neuropeptide that is involved in stress-related physiology and behavior, including control of the hypothalamic-pituitary-adrenal (HPA) axis. Members of the CRF family of neuropeptides, including urocortin 1 (Ucn 1), Ucn 2, and Ucn 3, bind to the G protein-coupled receptors, CRF type 1 (CRF1) and CRF2 receptors. In addition, CRF binding protein (CRFBP) binds both CRF and Ucn 1 and can modulate their activities. There are multiple mechanisms through which CRF-related peptides may influence emotional behavior, one of which is through altering the activity of brainstem neuromodulatory systems, including serotonergic systems. Corticotropin-releasing factor and CRF-related peptides act within the dorsal raphe nucleus (DR), the major source for serotonin (5-HT) in the brain, to alter the neuronal activity of specific subsets of serotonergic neurons and to influence stress-related behavior. CRF-containing axonal fibers innervate the DR in a topographically organized manner, which may contribute to the ability of CRF to alter the activity of specific subsets of serotonergic neurons. CRF and CRF-related peptides can either increase or decrease serotonergic neuronal firing rates and serotonin release, depending on their concentrations and on the specific CRF receptor subtype(s) involved. This review aims to describe the interactions between CRF-related peptides and serotonergic systems, the consequences for stress-related behavior, and implications for vulnerability to anxiety and affective disorders.